Nosocomial infection

Read more about Measures to Prevent and Control Transmission of Multidrug-Resistant Gram-Negative Bacilli (Excluding Carbapenemase-Producing Enterobacteriaceae) in Acute Care Settings in Québec
12 April 2018

Measures to Prevent and Control Transmission of Multidrug-Resistant Gram-Negative Bacilli (Excluding Carbapenemase-Producing Enterobacteriaceae) in Acute Care Settings in Québec

  • Comité sur les infections nosocomiales du Québec

Gram-negative bacilli (GNB) are bacteria frequently encountered in clinical settings, both as normal flora and as pathogens in a variety of infections.

The use of antibiotics has led to the emergence of various resistance mechanisms and some of these bacteria are now resistant to several classes of antibiotics.

This document was created to help healthcare-associated…

  • Professional practice guidelines
Read more about Prevention and control measures for Clostridium difficile in residential and long-term care facilities
11 April 2018

Prevention and control measures for Clostridium difficile in residential and long-term care facilities

  • Comité sur les infections nosocomiales du Québec
  • Since August 2004, Clostridium difficile associated diarrhea (CDAD) has undergone ongoing surveillance in all Quebec hospitals with more than 1,000 admissions annually. The surveillance has monitored the evolution of CDAD levels in health care facilities and confirmed their decrease. From an average of 9.1 cases/10,000 patient days in 2005-2006, the average rate has dropped…
  • Professional practice guidelines
Read more about Prevention and control measures for Candida auris in health care facilities
11 April 2018

Prevention and control measures for Candida auris in health care facilities

  • Comité sur les infections nosocomiales du Québec
  • Candida auris is an emerging microorganism that belongs to the yeast category. Increasingly, it is being found as a pathogen causing nosocomial fungal infections.
  • First identified in Japan in 2009 in a sample from a patient’s auditory canal (Satoh et al., 2009; ECDC, 2016; Rock, 2017), it has since been identified in up to 17 countries, spread across at…
  • Professional practice guidelines
Read more about Vascular Access–Related Bloodstream Infections in Hemodialysis Patients Surveillance results: 2016-2017
5 October 2017

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients Surveillance results: 2016-2017

  • Charles Frenette
  • Muleka Ngenda Muadi
  • Mélissa Trudeau
  • Christophe Garenc
  • Élise Fortin
  • Danielle Moisan
  • Isabelle Rocher
  • Jasmin Villeneuve
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016, to March 31st, 2017, 48 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 57,570 patient-periods (Table 1). Participating units reported 127 VARBSIs in 120 patients. Patient-periods involving a…

  • Monitoring report
Read more about Central Line–Associated Bloodstream Infections in Intensive Care Units Surveillance results: 2016-2017
5 October 2017

Central Line–Associated Bloodstream Infections in Intensive Care Units Surveillance results: 2016-2017

  • Élise Fortin
  • Muleka Ngenda Muadi
  • Caroline Quach-Thanh
  • Mélissa Trudeau
  • Christophe Garenc
  • Danielle Moisan
  • Isabelle Rocher
  • Jasmin Villeneuve
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016, to March 31st, 2017, 69 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 135,114 catheter days (Table 1). Participating ICUs report 133 CLABSIs in 125 patients. Incidence rates are 0.91 per 1,000 catheter days in…

  • Monitoring report
Read more about Hospital-Wide Healthcare-associated Bloodstream Infections Surveillance results: 2016-2017
5 October 2017

Hospital-Wide Healthcare-associated Bloodstream Infections Surveillance results: 2016-2017

  • Alex Carignan
  • Christophe Garenc
  • Élise Fortin
  • Danielle Moisan
  • Muleka Ngenda Muadi
  • Isabelle Rocher
  • Mélissa Trudeau
  • Jasmin Villeneuve
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016, to March 31st, 2017, 89 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,830,348 patient days (Table 1). Participating facilities reported 3,167 BSIs in 2,982 patients. The total incidence rate was 5.43 cases per 10,000 …

  • Monitoring report
Read more about Clostridium difficile–Associated Diarrhea Surveillance results: 2016-2017
5 October 2017

Clostridium difficile–Associated Diarrhea Surveillance results: 2016-2017

  • Christophe Garenc
  • Yves Longtin
  • Muleka Ngenda Muadi
  • Mélissa Trudeau
  • Danielle Moisan
  • Isabelle Rocher
  • Jasmin Villeneuve
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016 to March 31st, 2017, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,022,104 patient days (Table 1). These participating facilities reported 2,330 healthcare-associated CDAD (HA-CDAD), either acquired during a…

  • Monitoring report
Read more about Carbapenemase-Producing Gram Negative Bacilli Infections Surveillance results: 2016-2017
5 October 2017

Carbapenemase-Producing Gram Negative Bacilli Infections Surveillance results: 2016-2017

  • Christophe Garenc
  • Muleka Ngenda Muadi
  • Mélissa Trudeau
  • Christian Lavallée
  • Danielle Moisan
  • Isabelle Rocher
  • Jasmin Villeneuve
  • Claude Tremblay
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016, to March 31st, 2017, 82 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 4,448,999 patient days (Table 1). These facilities reported 17 healthcare-associated CPGNB (HA-CPGNB) infections among patients who acquired their strain during a current or previous…

  • Monitoring report
Read more about Vancomycin-Resistant Enterococci Infections Surveillance results: 2016-2017
5 October 2017

Vancomycin-Resistant Enterococci Infections Surveillance results: 2016-2017

  • Christophe Garenc
  • Muleka Ngenda Muadi
  • Mélissa Trudeau
  • Patrice Vigeant
  • Danielle Moisan
  • Isabelle Rocher
  • Jasmin Villeneuve
  • Claude Tremblay
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016 to March 31st, 2017, 89 healthcare facilities took part in the surveillance of vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,827,659 patient days (Table 1). These facilities reported 44 healthcare-associated VRE (HA-VRE) infections, either acquired during a current or previous hospitalization (categories 1a and 1b)…

  • Monitoring report
Read more about Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Surveillance results: 2016-2017
5 October 2017

Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Surveillance results: 2016-2017

  • Christophe Garenc
  • Danielle Moisan
  • Muleka Ngenda Muadi
  • Isabelle Rocher
  • Mélissa Trudeau
  • Jasmin Villeneuve
  • Claude Tremblay
  • Surveillance provinciale des infections nosocomiales

From April 1st, 2016 to March 31st, 2017, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,835,605 patient days (Table 1). Together, these facilities reported 66 cases of healthcare-associated MRSA bloodstream…

  • Monitoring report
RSS News Feed